1.
Vopr Onkol
; 57(5): 567-77, 2011.
Artigo
em Russo
| MEDLINE
| ID: mdl-22238925
Assuntos
Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais/análise , Neoplasias da Mama/tratamento farmacológico , Neoplasias Hormônio-Dependentes/tratamento farmacológico , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Inibidores da Aromatase/uso terapêutico , Neoplasias da Mama/química , Quimioterapia Adjuvante , Esquema de Medicação , Feminino , Humanos , Neoplasias Hormônio-Dependentes/química , Pré-Menopausa , Tamoxifeno/uso terapêutico , Resultado do Tratamento
2.
Vopr Onkol
; 57(5): 636-40, 2011.
Artigo
em Russo
| MEDLINE
| ID: mdl-22238935
RESUMO
Nanobiotechnology, defined as an arm of a nano-system is a rapidly developing area of medicine. Nanomaterials ranging from 1 to 1000 nm in size offer unique advantages of interaction with biological systems on the molecular level. Nanobiotechnologies can be used in definition, diagnosis and treatment of cancer thus leading to the new development of a new discipline--nanooncology. The potential of nanoparticles to be used in in-vivo tumor visualization, biomolecular profiling of tumor growth factors and targeted drug delivery is being studied. These methods stemming from nanotechnology may soon find a broad application in oncology.